EN
CN
EN
About us
About Accropeutics
Core Team
SAB
Milestone
Investors
Focus Areas
R&D
Publications
Pipeline
Partnerships
News
Join Us
Our Culture
Job Opportunities
Contact Us
About us
Back
About Accropeutics
Core Team
SAB
Milestone
Investors
Focus Areas
Back
R&D
Publications
Pipeline
Partnerships
News
Join Us
Back
Our Culture
Job Opportunities
Contact Us
Home
/
Focus Areas
/
Publications
Publications
Innovative pharmaceutical high-tech company
Scroll Down
May. 29, 2024
A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis
Learn More
May. 29, 2024
Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
Learn More
May. 29, 2024
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
Learn More
May. 29, 2024
Ring closure strategy leads to potent RIPK3 inhibitors
Learn More
